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Background: Following an outbreak of yellow fever in northern Uganda in December 2010, Ministry of Health
conducted a massive emergency vaccination campaign in January 2011. The reported vaccination coverage in
Pader District was 75.9%. Administrative coverage though timely, is affected by incorrect population estimates and
over or under reporting of vaccination doses administered. This paper presents the validated yellow fever
vaccination coverage following massive emergency immunization campaigns in Pader district.
Methods: A cross sectional cluster survey was carried out in May 2011 among communities in Pader district and
680 respondents were indentified using the modified World Health Organization (WHO) 40 × 17 cluster survey
sampling methodology. Respondents were aged nine months and above. Interviewer administered questionnaires
were used to collect data on demographic characteristics, vaccination status and reasons for none vaccination.
Vaccination status was assessed using self reports and vaccination card evidence. Our main outcomes were
measures of yellow fever vaccination coverage in each age-specific stratum, overall, and disaggregated by age and
sex, adjusting for the clustered design and the size of the population in each stratum.
Results: Of the 680 survey respondents, 654 (96.1%, 95% CI 94.9 – 97.8) reported being vaccinated during the last
campaign but only 353 (51.6%, 95% CI 47.2 – 56.1) had valid yellow fever vaccination cards. Of the 280 children
below 5 years, 269 (96.1%, 95% CI 93.7 – 98.7) were vaccinated and nearly all males 299 (96.9%, 95% CI 94.3 – 99.5)
were vaccinated. The main reasons for none vaccination were; having travelled out of Pader district during the
campaign period (40.0%), lack of transport to immunization posts (28.0%) and, sickness at the time of vaccination
(16.0%).
Conclusions: Our results show that actual yellow fever vaccination coverage was high and satisfactory in Pader
district since it was above the desired minimum threshold coverage of 80% according to World Health
Organization. Massive emergency vaccination done following an outbreak of Yellow fever achieved high population
coverage in Pader district. Active surveillance is necessary for early detection of yellow fever cases.
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Yellow fever is an acute vaccine preventable viral haem-
orrhagic disease found mainly in tropical regions of
Africa and America. It is caused by a Flavivirus which is
transmitted by mosquito bites and has a natural reser-
voir in non-human primates. The virus is endemic in
tropical areas of Africa and Latin America, with a com-
bined population of over 900 million people [1]. The
“yellow” in the name refers to the jaundice that affects
some patients. Approximately 200,000 cases and 30,000
deaths occur annually especially in Africa [2] where the
case-fatality rate ranges from 15–50% [3]. The yellow
fever virus can cause devastating epidemics of poten-
tially fatal, hemorrhagic disease. The disease can be con-
firmed through, serological testing by way of ELISA for
yellow fever virus-specific IgM or isolation of the virus
from blood samples. These are the recommended stand-
ard diagnostic tests for yellow fever although PCR tests
which detect the viral genetic material have been used
[1,4]. The number of yellow fever cases has increased
over the past two decades due to declining population
immunity to infection, deforestation, urbanization, popu-
lation movements and climate change. This disease has no
cure and treatment is symptomatic, aiming at reducing
symptoms for the comfort of the patient and mass vaccin-
ation is the most important preventive measure [5].
Immunization of people at risk interrupts human to hu-
man transmission of the yellow fever virus especially when
adequate vaccination coverage levels are reached. The vac-
cine is safe, affordable and highly effective, and appears to
provide protection for 30–35 years or more [1]. The vac-
cine provides effective immunity within one week for 95%
of persons vaccinated [6,7]. Despite mass vaccination cam-
paigns to prevent and control these outbreaks, the risk of
major yellow fever epidemics, especially in densely popu-
lated, poor urban settings, both in Africa and South
America, has greatly increased [8]. Consequently, yellow
fever is considered an emerging, or reemerging disease of
considerable importance.
In December 2010, the Ugandan Ministry of Health
(MOH) declared a Yellow fever outbreak based on nine
laboratory confirmed samples from the five districts of
Abim, Agago, Kitgum, Pader and Lamwo in northern
Uganda. This part of Uganda, home to game reserves
and national parks, borders South Sudan and Kenya
where previous cases of yellow fever have been reported
[9,10]. This was the largest ever recorded yellow fever
outbreak in the country with an overall attack rate of 13
cases per 100,000 population based on confirmed cases
[4]. A cumulative total of 181 confirmed cases with 45
deaths (CFR = 24.8%) were recorded, with no new cases
reported since February 2011 [4,11]. The CFR among
males (29.6%; 32/108) was nearly twice that of females
(17.8%; 13/73) and the ages of suspected yellow fevercases varied from 3 months to 83 years with a mean age
of 28.2 years and a standard deviation of 17.5 years [4].
Previous yellow fever outbreaks in Uganda had fewer or
single cases [12,13]. For about 40 years now, no yellow
fever cases had been reported in Uganda [14,15]. How-
ever, larger outbreaks had been reported in East Africa,
with attack rates (cases per 100,000 persons) of 6,800 in
Sudan [9] and 27.4 in Kenya [16]. In addition, the yellow
fever vaccine is not part of the Expanded Program for
Immunization (EPI) vaccines given routinely especially
to children under five. It is mainly people travelling
abroad from Uganda that are required to receive the
yellow fever vaccine.
The Ugandan Ministry of Health developed a national
response plan prioritizing surveillance and laboratory
confirmation, case management, social mobilization and
health education, and reactive vaccination to contain the
outbreak. The national response team included Ministry
of Health of Uganda, World Health Organization
(WHO), Uganda Red Cross society (URCS), United Na-
tions International Children Emergency Fund (UNICEF),
and the U.S. Centers for Disease Control and Prevention
(CDC). Others were African Field Epidemiology Net-
work (AFENET), RESPOND (Responding to emerging
pandemics and threats), MSF-Holland, Uganda National
Expanded Program on Immunization (UNEPI) and
World Vision. This campaign was conducted between
the 22nd and 26th of January 2011 and targeted all per-
sons aged 6 months and above in the affected districts.
Approximately one million people were targeted in the
affected region.
Pader district is found in northern Uganda and this re-
gion borders South Sudan which is prone to sporadic
yellow fever outbreaks [17]. In this district, residents
lead a primarily agricultural lifestyle, growing crops and
raising cattle, sheep, and poultry. Community settle-
ments near bushes and forests are common since most
people have just returned from internally displaced peo-
ples camps after the war in northern Uganda. They ven-
ture into the forests mainly for hunting and harvesting
bamboo for sale. Potential mosquito-breeding sites in-
clude baobab trees with tree holes, rock holes, and a
water reservoir on the outskirts of villages. The district
has a projected population of 205,898 [18] and the yel-
low fever attack rate was 2.9 cases per 100 000 popula-
tion with females being more affected than males.
During the response, 177 vaccination posts were cre-
ated, 354 health workers and 590 volunteers from 295
villages were identified and trained. Vaccination posts
were mainly health facilities (both public and private not
for profit), outreach sites for routine EPI vaccines and a
few schools. During the campaigns, Uganda Red Cross
society (URCS) supported community-based activities
such as social mobilization, transportation of vaccines
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supported organization of beneficiaries, issuing of vac-
cination cards and other support activities at the various
vaccination posts in this district. The target population
for vaccination in this campaign was all persons aged 6
months and above with a target vaccination coverage of
at least 80%. After the campaign, the reported or admin-
istrative yellow fever vaccination coverage was 75.9%
and this was below the targeted 80% [11]. Administrative
yellow fever vaccination coverages in the other districts
were: Abim 120.5%, Agago 81.6%, Kitgum 77.6% and
Lamwo 73.9% [11]. When the target coverage is not
reached, the potential for an epidemic increases since
there is a low prevalence of neutralizing antibodies to
the yellow fever virus from previous vaccination or nat-
urally acquired infection.
Underreporting of vaccine doses administered usually
results in underestimation of the coverage. It is import-
ant to conduct coverage surveys to validate reported
administrative coverages so as to inform imminent
(mop-up activities) and future immunizations strategies.
Probability-based surveys such as cluster surveys can es-
timate vaccination coverage even if the size of the target
population is not known [19,20]. The aim of this survey
was to estimate yellow fever vaccination coverage in
Pader district and determine the reasons for non vaccin-
ation to recommend possible mop-up actions, guide fu-
ture vaccination efforts and contribute to the control of
yellow fever in the country.
Methods
Study design
We estimated the yellow fever vaccination coverage
through a cluster survey based on the methodology
recommended by World Health Organization for deter-
mining vaccination coverages of routine EPI vaccines
[21]. Our study population was individuals aged nine
months and above living in the Pader district at the time
of the survey. We excluded the following from our study
population: Individuals and children less than 5 years
whose parents or caregivers were absent by the time of
the survey. This survey was conducted 3 months after
the massive emergency vaccination campaigns. We con-
sidered two main outcomes: vaccination status docu-
mented by the vaccination card (card only) and also by
considering verbal reports of vaccination (card and his-
tory or recall). We only considered vaccination status
assessed by cards and verbal reports from this campaign.
Sample size calculation
The required sample size was 680 individuals with the
following assumptions; a two-sided test with a precision
of 0.05, 17 respondents per cluster, design effect of 2
[22], proportion of those with complete vaccinationsbased on the previous administrative coverage of 75.9%
[11] and a non-response rate of 17% [23]. We needed 7
respondents from those below 5 years, 5 from those be-
tween 5 and 15 years and 5 from those above 15 years in
each cluster. This survey was also used to assess vaccin-
ation coverage for routine EPI vaccines for children
under five, the reason we needed 7 respondents from
this age group based on the WHO 30 by 7 cluster sam-
pling strategy [21].Sampling procedure
This post campaign evaluation of the yellow fever vac-
cination coverage was based on the WHO EPI coverage
survey methodology using the cluster sampling approach
[21]. In this method, villages were taken as clusters and
the process involved two stages of sampling. A list of all
villages containing registered voters was obtained from
the district returning officer. The total population of a
village was estimated based on the fact that the propor-
tion of registered voters was approximately 43% in each
village (this was the most recent population update data
available following national elections that occurred in
February 2011). The total population of Pader district
was estimated by summing up all the number of people
in each village. We then divided the total population of
the district by 40 (the desired number of clusters) to ob-
tain the sampling interval. A random start was obtained
and proportionate to size probability sampling (PPS) was
done to get all the 40 clusters systematically. The center
of each cluster was located with the help of a local guide
and we randomly determined the direction of movement
throughout the cluster. We identified the first household
randomly and then the next household to visit was the
one nearest to the first one. In each cluster, a random
sample of 17 individuals were selected taking seven from
those below 5 years, five from those between 5–15 years
and five from respondents above 15 years. Where we
found more than one eligible respondents for the differ-
ent age specific categories in a household, one respond-
ent was selected by simple random sampling.Survey instruments
We used the modified WHO cluster survey forms for
yellow fever vaccination for children and adults. The
cluster survey tools were pretested in five villages which
were not part of the study and were modified where
necessary. The instrument sought the identity of respon-
dents, awareness about the yellow fever vaccination
campaign and yellow fever vaccination status and rea-
sons for non vaccination. Most questions on the survey
instruments were close ended and information on vac-
cination status was obtained from vaccination cards
(where available) or from the respondent’s verbal history.
Bagonza et al. BMC Public Health 2013, 13:202 Page 4 of 7
http://www.biomedcentral.com/1471-2458/13/202For a vaccination card to be considered valid, it had to
be dated and signed by appropriate Health authorities.
Survey teams
The survey forms were administered by 30 trained inter-
viewers who were supervised by two central and five dis-
trict supervisors. Each team consisted of two to three
interviewers who were proficient in both English and the
local language (Acholi). Each district supervisor was re-
sponsible for two to three teams while the central super-
visors monitored all the teams. The survey teams used
vehicles to travel to the field and each team filled on
average 10 survey forms daily (approximately one cluster
per day). Face to face interviews were conducted with
randomly selected participants. Where we found more
than one eligible respondent in the household, one was
selected by simple random sampling. For children below
5 years, a present adult household member was surveyed
as a proxy regarding the child’s information. Data collec-
tion lasted five days and an individual was considered
vaccinated if there was card evidence or through positive
self reports. The supervisors and data collectors edited
survey tools at the end of each day for completeness and
consistency. Data were cleaned and stored on a daily
basis by central supervisors. In order to check the accur-
acy of data entered, cross checking the print of a data
set with a random number of survey forms picked from
the sample was done.
Data analysis
Data were coded and captured using Epi-Info 3.3.2 of
2005 version software and exported to STATA version
10.0 for analysis. Our main outcomes were measures of
yellow fever vaccination coverage in each age-specific
stratum, overall, and disaggregated by age and sex,
adjusting for the clustered design and the size of the
population in each stratum. The other outcomes were
reasons for not receiving yellow fever vaccination.
Ethical considerations
This survey was a programmatic research conducted in
collaboration with the Ugandan Ministry of Health and
WHO in response to an emergency public health out-
break (yellow fever) in northern Uganda. The Ministry
of Health and the Uganda National Council for Science
and Technology consider outbreak investigations and
the related programmatic evaluations/activities as public
health practice since the aim is to contain the outbreak.
In addition, we discussed our study with the research
and ethics committee of Makerere University School of
Public Health and obtained a waiver. We also sought
verbal consent since our study was non intrusive,
explained the risks and benefits, ensured privacy andconfidentiality since personal identifiers were not used
on survey tools.
Results
This post campaign evaluation survey for yellow fever
vaccination coverage was conducted between the 6th and
12th of May 2011. Of the 680 study participants, only
679 (99.8%) were included in our analysis. One respond-
ent (0.2%) was excluded from further analysis on ac-
count of having an incompletely filled survey form.
More than half of the respondents (54.6%) were females.
Yellow fever vaccination coverage
Table 1 shows results of yellow fever vaccination status
based on vaccination card evidence or recall disaggregated
by sex and age. The overall yellow fever vaccination cover-
age in Pader district was 96.1% (95% CI 94.3 - 97.8). By
age, the highest vaccination coverage was among respon-
dents between 5 to 15 years, 98.0%, (95% CI 96.3 – 99.9).
Vaccination coverages for children below 5 years and re-
spondents above 15 years were 96.1% (95% CI 93.7 – 98.7)
and 94.9% (95% CI 91.9 – 98.1) respectively. A higher pro-
portion of males were vaccinated 96.9%, (95% CI 94.3 –
99.5) compared to females 95.4%, (95% CI 92.9 – 97.9).
More than half of the respondents 51.6% (95% CI 47.2 –
56.1) had a yellow fever vaccination card as evidence of
vaccination while 44.3% (301) reported that they had re-
ceived vaccination but had no card evidence. In this sur-
vey, no invalid or fake cards were seen and a card was
valid if it was signed and stamped by the relevant health
authorities. Only 3.7% (25) of the respondents did not re-
ceive yellow fever vaccination.
Reasons for not receiving yellow fever vaccination during
the campaigns
From Table 2, the main reasons for failure to receive yel-
low fever vaccination were: having travelled out of Pader
district, distance/lack of transport to the immunization
posts and sickness. Other reasons included: being at
school, long waiting time and rudeness of health workers.
Discussion
This post campaign survey, which was part of the out-
break response activities by the Ugandan Ministry of
Health and WHO, was done to evaluate the vaccination
coverage following an outbreak of yellow fever in northern
Uganda. In Pader district, the overall estimate of yellow
fever vaccination coverage was 96.1% with a card reten-
tion rate of 51.6%. The main reasons for not receiving vac-
cination during the mass campaign were: having travelled
out of the district, lack of transport to vaccination posts
and being sick during the campaigns. Others reasons
were: being sick during the campaigns, being at school
and rudeness of health workers at vaccination posts.
Table 1 Yellow fever vaccination coverage by age and sex in Pader district
Variables (n = 679) Vaccination (Card only) Vaccination ( Card+/−recall)
Frequency % (95% CI) Frequency % (95% CI)
Age
Below 5 years 147 52.5 (46.6 – 58.3) 269 96.1 (93.7 – 98.7)
5 to 15 years 105 52.2 (45.3 – 59.2) 197 98.0 (96.3 – 99.9)
Above 15 years 101 51.0 (43.9 – 58.0) 188 94.9 (91.9 – 98.1)
Sex
Female 195 50.7 (44.9 – 56.3) 355 95.4(92.9 – 97.9)
Male 158 51.3 (45.7 – 56.8) 299 96.9(94.3 – 99.5)
Overall vaccination coverage 353 51.6 (47.2 – 56.1) 654 96.1(94.9 – 97.8)
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in Pader district exceeded 90% and was above the de-
sired minimum threshold coverage of 80% according to
WHO [24]. This theoretically implies that a need to con-
duct an emergency follow up revaccination campaign
was avoided since almost everybody (96.3%) was protected
against yellow fever. When the desired immunization
coverage is exceeded, the potential for human to human
transmission reduces since a higher proportion of people
at risk have circulating yellow fever antibodies. The other
affected districts also reported high vaccination coverage
estimates: Abim 95.4%, Agago 97.5%, Kitgum 97.8% and
Lamwo 97.1%. A cluster survey done in internally
displaced people’s camps in Liberia following mass yellow
fever vaccination campaigns revealed comparably high
coverages [25]. However, a high vaccination coverage
doesn’t necessarily mean that the country is not at risk
since Uganda borders South Sudan which experiences
sporadic yellow fever outbreaks [17]. Secondly, yellow
fever vaccination is not routinely given along with the rou-
tine EPI vaccines thus only people who travel out of the
country might be protected against the disease. Indeed
one case of yellow fever was reported in October 2012 in
Agago district, northern Uganda and this was confirmed
by the Epidemiology and Surveillance unit of Ministry of
Health [26].
Our study found a difference between the survey and
administrative coverage (75.9%) and this is in agreement
with previous studies which suggest that the quality ofTable 2 Reasons for not receiving Yellow fever
vaccination during the campaigns in Pader district
Reasons for none vaccination Frequency (%)
Having travelled out of Pader district 10 (40.0)
Lack of transport to vaccination posts 7 (28.0)
Being sick during the vaccination campaigns 4 (16.0)
Being at school during the campaigns 2 (8.0)
Long waiting time at vaccination posts 1(4.0)
Rudeness of health workers at vaccination posts 1(4.0)administrative coverage data is unreliable [27,28]. Such
data, often times over or under estimates coverage due
to wrong population estimates and incomplete tallying
or reporting of vaccination doses. This is compounded
by poorly documented shifts in population and reliance
on imprecise or outdated census data [23,25]. To our
knowledge, this was the first reported cluster survey to
evaluate yellow vaccination coverage in Uganda and no
yellow fever outbreaks had been reported in Uganda in
the last 40 years [14]. One possible reason for the discrep-
ancy between administrative and our survey coverage is
that the Ministry of Health during the immunization cam-
paigns relied on old projected population estimates from
the district population office. Secondly, the estimated tar-
get population used to calculate the administrative cover-
age might not have taken into account new residents,
migrant workers and nomadic population.
Although, the yellow fever vaccination coverage ex-
ceeded 90% by self report (card or recall), only half of
the respondents had cards as evidence for vaccination. A
similar vaccination card retention rates was reported in
a cluster survey for routine childhood EPI and yellow
fever vaccination campaigns in West Africa [29]. In our
study, we considered both card evidence and recall to
estimate vaccination status. A previous survey showed
that caregiver recall is highly sensitive (>90%) and fairly
accurate in determining vaccination status [30]. Because
of the high sensitivity of caregiver recall in estimating
vaccination status, it is now acceptable practice both in
developed and resource constrained countries to use
caregiver recall in estimating immunization coverage
[30,31]. In our survey, we validated vaccination status by
recall by also asking the site of vaccination during the
campaigns. The low card retention rate after a short
period of mass immunization (3 months) may suggests
programmatic or logistical challenges in organizing vac-
cination activities. It is also possible that not all people
vaccinated actually received their vaccination cards. Al-
though there were unconfirmed reports of fake yellow
fever vaccination cards being sold in clinics in Kampala,
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[32], no fake vaccination cards were found during our
survey.
Our study revealed that the 5–15 years age category
had the highest vaccination coverage. This is probably
due to the fact that this age category is easy to mobilize
since most of them are in schools. Nearly fifty percent of
those not vaccinated had travelled out of the district
possibly to engage in other gainful activities during the
vaccination exercise. Furthermore, it is possible that
adults are more likely to question the rationale of vaccin-
ation than children and this may influence their decision
regarding vaccination. For children below 5 years, chances
of being vaccinated largely depend on adults (caregivers).
Others reasons for non vaccination from our study were
lack of transport, sickness, long waiting time and rudeness
of health workers. This is in agreement with studies done
to assess the determinants of vaccination coverage in
Nairobi Kenya and Niger [33,34]. Such factors are major
barriers to access of immunization and other health ser-
vices by communities and thus may reinforce poor health
seeking behaviors. This also reinforces the need for con-
tinuous staff motivation and regular supervision to over-
come health system challenges to vaccination campaigns.
Limitations of our survey
For children, interviews were conducted by proxy and
this could have affected the accuracy of information.
However, proxy interviewees were members of the same
household and usually very familiar with the demo-
graphic and vaccination status of the selected person.
Secondly recall bias may have been introduced since self
reports were used to ascertain vaccination status for
those who did not have yellow fever vaccination cards
for the last campaigns. One way to minimize this is to
conduct evaluation survey immediately after campaigns.
This may not be feasible in Uganda which at times relies
on logistical support from WHO to carry out such eval-
uations. Cluster lot quality assurance sampling tech-
niques can be used to monitor coverage as soon as the
campaign ends or even before its end [35]. Since we did
not have the proportion of population vaccinated per
strata during the campaigns, calculating overall vaccin-
ation coverage without taking this into account may
have resulted in less accurate results if there were great
imbalance between strata.
Our coverage estimates are only really valid for card
and history since these figures are above 90%. The
estimations by card only are approximately 50% so the
sample size was probably too small to obtain precise es-
timates. We also asked about the site of vaccination or
injection to validate reported vaccination status. Also,
because routine EPI vaccination programs were going
on in the district, bias by inadvertently attributing yellowfever immunization to another vaccine was likely. Since
vaccination cards for this yellow fever immunization cam-
paign were different from the routine EPI immunization
cards, we believe such bias did not affect our data greatly.
With the use of standard yellow fever survey tools, infor-
mation on household size, distance from vaccination
posts, religion, reasons for not having cards was not
captured hence we could not draw conclusions on these
variables.
Conclusions
The mass vaccination campaigns against yellow fever in
Pader district were successful since the estimated cover-
age exceeded the desired threshold of 80%. Conse-
quently, mop up revaccination activities were avoided.
However, active surveillance activities for early case de-
tection of yellow fever are necessary since this area bor-
ders South Sudan which is prone to sporadic yellow
fever outbreaks. Mass campaign evaluations should be
done immediately or shortly after response activities in
order to estimate vaccination coverage more accurately.
In addition, more efforts should be put to ensure
immunization card retention. In future, more vaccin-
ation posts should be established to increase access to
immunization services by the population. Yellow fever
survey tools could be modified to capture information
on: reasons for poor card retention, religion, household
size and distance from vaccination posts since such vari-
ables might affect vaccination status.
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